Pharmaceutical e -commerce platform first refers to the concept of "digital wisdom medical" to promote the high -quality development of the medical service system

Cover Journalist Fu Wenchao

In recent years, the demand for multi -level and diverse medical and health services has continued to grow, and an urgent requirement to the medical service system: accelerate the improvement of the quality and service level of medical health supply.

On August 20, Jingdong Health first demonstrated the "digital wisdom medical" solution system that promoted the medical service system to achieve high -quality development, and released a comprehensive solution for different application scenarios for hospitals. JD Health believes that Nuzhi Medical is a capability system. It covers the entire process of informatization of the medical service system. It is a comprehensive manifestation of digital and intelligent in terms of technology, models, and management.

JD Health CEO Kim Ensin said that the capabilities of digital medical integration digital intelligence technology, big data application, operational support, and supply chain management will become a new engine with high -quality development of the medical service system.

It is understood that the digital medical solution system includes: "Technical Opening Platform", "Big Data Application System", "Operating Support System" and "Supply Chain Management System", and through integrated delivery models Digital intelligent medical solution.

Among them, the "technical open platform" solves the technical upgrade needs of the medical service system, including cloud shadow, intelligent follow -up, mutual medical brain and other solutions, which helps to shorten the complicated project cycle of the medical service system. In addition, its modular application is more convenient for iterative upgrades, and efficient technology can promote the establishment of industry standards.

The reporter learned that current pharmaceutical e -commerce can be divided into three categories: B2B, B2C, and O2O according to their upstream and downstream and business models. It is understood that the main players of the pharmaceutical e -commerce market B2C include -Jingdong Health, Ali Health, 1 Pharmaceutical Network, 360 Good Pharmaceutical, Good Pharmacist, etc.

According to Zhongkang CMH data, in the first half of 2022, the market size of the pharmaceutical e -commerce B2C reached 70.7 billion yuan, an increase of 25%year -on -year; in June, it was driven by e -commerce promotion, a year -on -year increase of 26%. Among them, the sales of prescription drugs in e -commerce increased by 51%year -on -year, the highest growth rate was the highest; OTC increased by 4%year -on -year.

In addition, Liang Zhigang, director of the Information Center of Xuanwu Hospital of the Capital Medical University, said that the development of digital medical treatment must always be centered on patient service, to pass the barriers or boundaries of online and offline services, optimize the service process, allow patients to run less, let the information run more. road.

- END -